We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Gimv NV (GIMB) Npv

Sell:€44.15 Buy:€44.70 Change: €0.55 (1.25%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:€44.15
Buy:€44.70
Change: €0.55 (1.25%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:€44.15
Buy:€44.70
Change: €0.55 (1.25%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Gimv NV is a Belgium-based investment company. The five segments of the Company are investment platforms: Consumer, Healthcare, Life sciences, Smart industries, Sustainable cities. The Consumer platform focuses on companies that respond to current and future consumer needs and preferences. In the Health and Care platform, the Company invests in biotechnology, medical technology, and service companies in the health & care sector. Through Smart Industries platform the Company invests in innovation and intelligent technologies. The Sustainable Cities platform focuses on construction & materials, energy and environment, transport, logistics and mobility, and industrial services. The Company invests as well, in third-party funds and infrastructure.

Contact details

Address:
Karel Oomsstraat 37
ANTWERPEN
2018
Belgium
Telephone:
+32 (3) 2902100
Website:
https://www.gimv.com/en

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GIMB
ISIN:
BE0003699130
Market cap:
€1.23 billion
Shares in issue:
27.88 million
Sector:
Asset Management & Custody Banks
Exchange:
Euronext Brussels
Country:
Belgium
Currency:
Euro
Indices:
n/a

Key personnel

  • Koen Dejonckheere
    Chief Executive Officer, Executive Director
  • Kristof Vande Capelle
    Chief Financial Officer
  • Koen Bouckaert
    Managing Partner - Head Consumer
  • Bart Diels
    Managing Partner - Head Health and Care
  • Erik Mampaey
    Managing Partner - Head Sustainable Cities
  • Tom Van De Voorde
    Managing Partner - Head Smart Industries
  • Bram Vanparys
    Managing Partner - Head Life Sciences
  • Edmond Bastijns
    Chief Legal Officer, Secretary General

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.